Legend Biotech annual operating margin
2023
2024
2025
Legend Biotech Operating Margin Growth & History (LEGN)
Legend Biotech's operating margin was −13.27% for fiscal 2025.
View full Legend Biotech company overviewLegend Biotech annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −13.27% | +36.08 pp |
| 2024 | 2024-12-31 | −49.34% | +135.86 pp |
| 2023 | 2023-12-31 | −185.21% | — |
Legend Biotech quarterly operating margin
Q3.24
Q3.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | −15.96% | — |
| Q3 2024 | 2024-09-30 | −43.92% | — |
Legend Biotech operating margin trends
Across the available reported history, Legend Biotech's operating margin increased from −49.34% to −13.27%, a change of +36.08 percentage points. The latest reported quarter, Q3 2025, shows −15.96%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Legend Biotech filings at SEC.gov ↗